Home » Stocks » GCAN

The Greater Cannabis Company, Inc. (GCAN)

Stock Price: $0.0062 USD 0.0020 (31.92%)
Updated Jan 15, 2021 3:59 PM EST - Market closed
Market Cap 2.26M
Revenue (ttm) 50,284
Net Income (ttm) -1.66M
Shares Out 84.17M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $0.0062
Previous Close $0.0047
Change ($) 0.0020
Change (%) 31.92%
Day's Open 0.0050
Day's Range 0.0048 - 0.0115
Day's Volume 332,323,324
52-Week Range 0.0018 - 0.0371

News

There are no news available yet.

About GCAN

The Greater Cannabis Company, a biopharmaceutical company, focuses on the development and commercialization of technology for transmucosal delivery of legal medical or recreational cannabis and cannabinoids. The company intends to commercialize the technology by sublicensing or partnering with licensed producers, distributors, processors, consumer product, and pharmaceutical companies in the legal cannabis and CBD industries to bring the product to the North American market in legal medical and recreational cannabis and CBD segments. The Greate... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
CEO
Aitan Zacharin
Employees
2
Stock Exchange
OTCMKTS
Ticker Symbol
GCAN
Full Company Profile

Financial Performance

In 2019, GCAN's revenue was $7,120, a decrease of -92.53% compared to the previous year's $95,375. Losses were -$1.65 million, 96.5% more than in 2018.

Financial Statements